Audiogenic reflex seizures in cats

Journal of Feline Medicine and Surgery

Volumn 18, Issue 4, 2016, Pages 328-336

  Lowrie, Mark ^a   Bessant, Claire ^b   Harvey, Robert J ^c   Sparkes, Andrew ^b   Garosi, Laurent ^a  

^a DAVIES VETERINARY SPECIALISTS   (United Kingdom)

^b International Cat Care   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CAT; CAT DISEASES; PATHOPHYSIOLOGY; QUESTIONNAIRE; REFLEX EPILEPSY; SEIZURE; VETERINARY;

ANIMALS; CAT DISEASES; CATS; EPILEPSY, REFLEX; SEIZURES; SURVEYS AND QUESTIONNAIRES;

EID: 84961898791     PISSN: 1098612X     EISSN: 15322750     Source Type: Journal    
DOI: 10.1177/1098612X15582080     Document Type: Article

References (56)

1. J.EngelJr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia2001; 42: 796–803.
2. C.P.Panayiotopoulos. Reflex seizures and reflex epilepsies. In: The epilepsies: seizures, syndromes and management. Oxford: Bladon Medical Publishing, 2005, pp 449–496.
3. R.A.BrowningC.WangD.K.Nelson. Effect of precollicular transection on audiogenic seizures in genetically epilepsy-prone rats. Exp Neurol1999; 155: 295–301.
4. R.P.Kesner. Subcortical mechanisms of audiogenic seizures. Exp Neurol1966; 15: 192–205.
5. N.Garcia-Cairasco. A critical review on the participation of inferior colliculus in acoustic-motor and acoustic-limbic networks involved in the expression of acute and kindled audiogenic seizures. Hear Res2002; 168: 208–222.
6. M.VergnesM.KiesmannC.Marescaux. Kindling of audiogenic seizures in the rat. Int J Neurosci1987; 36: 167–176.
7. M.KiesmannC.MarescauxM.Vergnes. Audiogenic seizures in Wistar rats before and after repeated auditory stimuli: clinical, pharmacological, and electroencephalographic studies. J Neural Transm1988; 72: 235–244.
8. H.KlitgaardA.MatagneK.Gobert. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol1998; 353: 191–206.
9. C.Ji-qunK.IshiharaT.Nagayama. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Epilepsia2005; 46: 1362–1370.
10. M.NoyerM.GillardA.Matagne. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol1995; 286: 137–146.
11. B.FuksM.GillardP.Michel. Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines. Eur J Pharmacol2003; 478: 11–19.
12. G.L.KraussA.BerginR.E.Kramer. Suppression of post-hypoxic and post encephalitic myoclonus with levetiracetam. Neurology 200; 56: 411–412.
13. S.NoachtarE.AndermannP.Meyvisch. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology2008; 70: 607–616.
14. W.E.RosenfeldS.BenbadisP.Edrich. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies. Epilepsy Res2009; 85: 72–80.
15. M.R.Gamble. Sound and its significance for laboratory animals. Biol Rev Camb Philos Soc1982; 57: 395–421.
16. J.D.MillerC.S.WatsonW.P.Covell. Deafening effects of noise on the cat. Acta Otolaryngol Suppl1963; 176: 3–91.
17. N.CharizopoulouA.LelliM.Schraders. Gipc3 mutations associated with audiogenic seizures and sensorineural hearing loss in mouse and human. Nat Commun2011; 2: 201.
18. L.KegelE.AuninD.Meijer. LGI proteins in the nervous system. ASN Neuro2013; 5: 167–181.
19. S.DelmaghaniA.AghaieN.Michalski. Defect in the gene encoding the EAR/EPTP domain-containing protein TSPEAR cases DFNB98 profound deafness. Hum Mol Genet2012; 21: 3835–3844.
20. E.H.SeppäläT.S.JokinenFukata. LGI2 truncation causes a remitting focal epilepsy in dogs. PLoS Genet2011; 7: e1002194.
21. S.L.SkradskiA.M.ClarkH.Jiang. A novel gene causing a mendelian audiogenic mouse epilepsy. Neuron2001; 31: 537–544.
22. H.YagiY.TakamuraT.Yoneda. Vlgr1 knockout mice show audiogenic seizure susceptibility. J Neurochem2005; 92: 191–202.
23. D.R.McMillanP.C.White. Loss of the transmembrane and cytoplasmic domains of the very large G-protein-coupled receptor-1 (VLGR1 or Mass1) causes audiogenic seizures in mice. Mol Cell Neurosci2004; 26: 322–329.
24. K.R.JohnsonQ.Y.ZhengM.D.Weston. The Mass1 frings mutation underlies early onset hearing impairment in BUB/BnJ mice, a model for the auditory pathology of Usher syndrome IIC. Genomics2005; 85: 582–590.
25. A.ShahwanM.FarrellN.Delanty. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol2005; 4: 239–248.
26. H.LohiE.J.YoungS.N.Fitzmaurice. Expanded repeat in canine epilepsy. Science2005; 307: 81.
27. D.N.SandersF.H.FariasG.S.Johnson. A mutation in canine PPT1 causes early onset neuronal ceroid lipofuscinosis in a Dachshund. Mol Genet Metab2010; 100: 349–356.
28. T.AwanoM.L.KatzD.P.O’Brien. A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis. Mol Genet Metab2006; 89: 254–260.
29. S.A.MelvilleC.L.WilsonC.S.Chiang. A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs. Genomics2005; 86: 287–294.
30. M.L.KatzF.H.FariasD.N.Sanders. A missense mutation in canine CLN6 in an Australian shepherd with neuronal ceroid lipofuscinosis. J Biomed Biotechnol2011; 2011: 198042.
31. M.L.KatzS.KhanT.Awano. A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis. Biochem Biophys Res Commun2005; 327: 541–547.
32. T.AwanoM.L.KatzD.P.O’Brien. A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis. Mol Genet Metab2006; 87: 341–348.
33. F.H.FariasR.ZengG.S.Johnson. A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers. Neurobiol Dis2011; 42: 468–474.
34. M.AbitbolJ.L.ThibaudN.J.Olby. A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis. Proc Natl Acad Sci U S A2010; 107: 14775–14780.
35. S.N.FitzmauriceH.C.PowellG.D.Shelton. Familial myoclonic epilepsy with skeletal muscle polyglucosan bodies in the miniature wirehaired dachshund. J Vet Intern Med1999; 13: 239.
36. S.N.FitzmauriceC.RusbridgeG.D.Shelton. Familial myoclonic epilepsy in the miniature wirehaired dachshund. J Vet Intern Med2001; 15: 72–73.
37. C.RusbridgeS.N.FitzmauriceH.Lohi. Treatment of Lafora disease (inherited myoclonic epilepsy) in dogs. J Vet Intern Med2005; 19: 289.
38. E.KaiserK.KrauserD.Schwartz-Porsche. Lafora’s disease (progressive myoclonus epilepsy) in the Basset Hound – early diagnosis by muscle biopsy. Tierärztl Prax1991; 19: 290–295.
39. J.M.HollandW.C.DavisD.J.Prieur. Lafora’s disease in the dog. A comparative study. Am J Pathol1970; 58: 509–530.
40. Z.JianM.R.AlleyJ.Cayzer. Lafora’s disease in an epileptic Basset hound. N Z Vet J1990; 38: 75–79.
41. T.L.Tomchick. Familial Lafora’s disease in the beagle dog. Fed Proc1973; 32: 821.
42. G.A.HegrebergG.A.Padgett. Inherited progressive epilepsy of the dog with comparisons to Lafora’s disease of man. Fed Proc1976; 35: 1202–1205.
43. K.E.DavisJ.W.FinnieP.T.Hooper. Lafora’s disease in a dog. Aust Vet J1990; 67: 192–193.
44. D.L.Whitenack. Neuronal glycoproteinosis (Lafora’s disease) in the dog. American Association of Veterinary Laboratory Diagnosticians, 21st Annual Proceedings; 1978, Madison, WI. 1978, pp 493–496.
45. P.K.CusickA.M.CameronA.J.Parker. Canine neuronal glycoproteinosis – Lafora’s disease in the dog. J Am Anim Hosp Assoc1976; 12: 518–521.
46. T.SchoemanJ.WilliamsE.van Wilpe. Polyglucosan storage disease in a dog resembling Lafora’s disease. J Vet Intern Med2002; 16: 201–207.
47. H.GredalM.BerendtP.S.Leifsson. Progressive myoclonus epilepsy in a beagle. J Small Anim Pract2003; 44: 511–514.
48. A.A.WebbC.McMillanC.L.Cullen. Lafora disease as a cause of visually exacerbated myoclonic attacks in a dog. Can Vet J2009; 50: 963–967.
49. B.A.MinassianJ.R.LeeJ.A.Herbrick. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet1998; 20: 171–174.
50. E.M.ChanD.E.BulmanA.D.Paterson. Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22. J Med Genet2003; 40: 671–675.
51. C.Gómez-AbadP.Gómez-GarreE.Gutiérrez-Delicado. Lafora disease due to EPM2B mutations: a clinical and genetic study. Neurology2005; 64: 982–986.
52. P.D.GreenP.B.Little. Neuronal ceroid-lipofuscin storage in Siamese cats. Can J Comp Med1974; 38: 207–212.
53. R.BildfellC.MatwichukS.Mitchell. Neuronal ceroid-lipofuscinosis in a cat. Vet Pathol1995; 32: 485–488.
54. M.KuwamuraM.NakagawaM.Nabe. Neuronal ceroid-lipofuscinosis in a Japanese domestic shorthair cat. J Vet Med Sci2009; 71: 665–667.
55. Y.FurusawaK.MizukamiA.Yabuki. Mutational analysis of the feline CLN3 gene and an ultrastructural evaluation of lysosomal storage materials in a cat with neuronal ceroid lipofuscinosis: an investigation into the molecular basis of the disease. Vet J2012; 194: 425–428.
56. M.D.ChalkleyA.G.ArmienD.H.Gilliam. Characterization of neuronal ceroid-lipofuscinosis in 3 cats. Vet Pathol2014; 51: 796–804.